Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate the therapeutic effect of shockwave therapy on reducing pruritus in neurodermatitis patients.
Based on the occurrence of side effects caused by conventional medication for prolonged employment, dermatologists and patients show solicitude for multifaceted effective methods to control the chronic and relapsing nature of neurodermatitis. Although new modalities are continuously coming up for pruritus, there remains a great gap for providing symptom relief. Furthermore, there is a lack in the quantitative knowledge and information in the published studies about benefits of shockwave therapy on the treatment of pruritus in neurodermatitis patients. So, this study is designed to outline the therapeutic efficacy of shockwave therapy on the treatment of pruritus in neurodermatitis patients.
Age
55 - 75 years
Sex
ALL
Healthy Volunteers
No
Suez Canal University Hospital
Ismailia, Egypt
Start Date
December 15, 2024
Primary Completion Date
September 15, 2025
Completion Date
October 25, 2025
Last Updated
March 9, 2026
34
ACTUAL participants
Shockwave therapy
DEVICE
Emollients & corticosteroids
DRUG
Lead Sponsor
Cairo University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions